Legend Biotech Corporation

LEGN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$17.61+0.17%

2026-09-18

Financials

Valuation Metrics

Legend Biotech Corporation's Market Cap is $3.27B. At end of 2025 it was $4.02B. Ranked #1673 of 3,121 in US market (top 54%), #596 of 1,463 on NASDAQ (top 41%), #101 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 38%) by Market Cap.

Investment Metrics(as of 2026-09-19)

Metric	Value	Rank
Size
Market Cap	$3.27B	US#1,673/3,121 Sec#101/266
Revenue	$1.27B	US#1,747/3,121 Sec#46/266
Net Income	$-92M	US—/3,121 Sec—/266
Total Assets	$1.75B	US#2,171/3,121 Sec#59/266
Net Assets	$1.23B	US#1,633/3,121 Sec#54/266
Value
P/B	2.66x	US#1,612/3,121 Sec#77/266
P/S	2.57x	US#1,528/3,121 Sec#38/266
FCF Yield	-7.81%	US—/3,121 Sec—/266
Profitability
ROE	-7.45%	US#2,320/3,121 Sec#76/266
ROA	-5.23%	US#2,527/3,121 Sec#88/266
Op. Margin	-4.42%	US#2,469/3,121 Sec#83/266
Revenue Growth	59.54%	US#182/3,121 Sec#43/266
Financial Health
Debt Ratio	42.40%	US#479/3,121 Sec#133/266
Total Debt	$278M	US#2,134/3,121 Sec#83/266
FCF	$-256M	US#2,825/3,121 Sec#227/266
Cash	$673M	US#888/3,121 Sec#42/266
Current Ratio	3.04x	US#781/3,121 Sec#191/266
Performance
1Y Return	-49.91%	US#2,909/3,121 Sec#245/266
1M Return	-22.08%	US#2,973/3,121 Sec#242/266
From 52W High	-53.04%	US#2,798/3,121 Sec#223/266
1Y MDD	-53.14%	US#2,576/3,121 Sec#193/266
Trading
Volume	2,658,673 shares	US#853/3,121 Sec#85/266
Trading Value	$47M	US#1,540/3,121 Sec#119/266
Per Share
EPS	$-0.49	US—/3,121 Sec—/266
BPS	$6.62	US#2,133/3,121 Sec#106/266